INKT
Mink Therapeutics Inc
12.20$
-1.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.7% | 79.0% | 87.0% | 91.8% | 89.2% | 87.2% | 83.9% | 81.0% | 97.1% | 97.3% | 96.6% | 96.7% | |
| 85.8% | 74.0% | 84.4% | 90.2% | 85.8% | 80.0% | 75.8% | 67.7% | 95.4% | 93.8% | 91.8% | 91.6% | |
| 85.8% | 74.0% | 84.4% | 90.2% | 85.8% | 80.0% | 75.8% | 67.7% | 95.4% | 93.8% | 91.8% | 91.6% | |
| 282.0% | 496.6% | 394.4% | 260.6% | 338.0% | 442.4% | 610.7% | 1,113.9% | 190.3% | 199.9% | 222.3% | 245.9% | |
| 139.3% | 250.5% | 161.1% | 98.3% | 100.3% | 121.7% | 284.0% | 529.8% | 89.8% | 91.5% | 70.2% | 78.7% | |
| – | – | – | – | – | – | 119.9% | 221.6% | 38.3% | 36.4% | – | – | |
| 57.4% | 85.9% | 50.6% | 31.0% | 32.0% | 47.7% | 62.4% | 133.4% | 24.7% | 24.1% | 32.7% | 40.8% | |
| – | – | 61.1% | 42.7% | 62.5% | 86.1% | – | – | – | – | – | – | |
| -182.0% | -396.6% | -294.4% | -160.6% | -238.0% | -342.4% | -510.7% | -1,013.9% | -90.3% | -99.9% | -122.3% | -145.9% | |
| -1,714.6% | -2,930.3% | -1,990.3% | -1,355.3% | -1,921.7% | -2,520.3% | -3,443.6% | -6,085.4% | -1,029.6% | -1,100.3% | -1,536.3% | -1,690.5% | |
| 46.2% | 75.9% | 50.3% | 36.0% | 53.6% | 66.0% | 92.9% | 160.3% | 29.7% | 30.0% | 46.2% | 52.2% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.